Lionco Pharmaceutical Group Co., Ltd.SSE: 603669

Announcement on Conversion Result of Convertible Bonds and Share Changes

· Issued by Lionco Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

Lionco Pharmaceutical Group Co., Ltd. has announced the results of the conversion of its convertible bonds and the resulting changes in share capital. The announcement details the amount converted and the number of shares created from the conversion, along with the total amount of convertible bonds that remain unconverted. It also outlines the changes in the company's share capital due to the conversion and share buybacks that have occurred.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Conversion Result of Convertible Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Lionco Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Lionco Pharmaceutical

Later from Lionco Pharmaceutical

All Lionco Pharmaceutical news releases